Latest from the Blog

1. October 8, 2021

   Advocacy in Action: Updates on the Childhood Cancer STAR Act and Childhood Cancer Data Initiative

   

   The Childhood Cancer STAR Act and Childhood Cancer Data Initiative (CCDI) are major federal government-led initiatives that exist in part because of years of advocacy work by members of the brain tumor and childhood cancer communities. As we reflect back on Childhood Cancer Awareness Month (CCAM) this past September, we want to share updates on […]

   Read more | 

   Tags: advocacy, brain cancer, brain tumor, Cancer, childhood cancer, NCI, pediatric, pediatric brain tumor, pediatric cancer, pediatrics
2. October 5, 2021

   NBTS Brain Tumor Clinical Trials Report: Q3 2021

   

   It can be hard to keep track of new brain tumor clinical trial opportunities opening across the United States, especially as we continue to navigate the public health crisis created by the coronavirus (COVID-19). There are many clinical trials actively enrolling patients, and this report provides a summary of the studies that have recently opened […]

   Read more | 

   Tags: brain cancer, brain tumor, childhood cancer, Clinical trials, DIPG, Ependymoma, GBM, glioblastoma, glioma, high-grade glioma, immunotherapy, Medulloblastoma, pediatric brain tumor, Treatment
3. July 15, 2021

   What You Need to Know About the New Updates to Brain Tumor Classifications and Grades

   

   The World Health Organization (WHO) sponsors a group of pathologists and clinicians who are experts in brain and spinal cord tumors to develop the criteria for how brain tumors are classified and graded. As the scientific field continues to better understand the biology of brain tumors, a separate organization, cIMPACT (the Consortium to Inform Molecular […]

   Read more | 

   Tags: astrocytoma, brain cancer, brain tumor, Ependymoma, GBM, glioblastoma, glioma, high-grade glioma, low-grade glioma, meningioma, oligo, Oligodendroglioma, pediatric brain tumor, pediatrics, precision medicine, Treatment